Chiffres en millions de dollars américains. L'exercice financier va de février à janvier.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Revenus
280,694
275,250
260,295
231,981
215,824
191,909
Croissance des revenus (H/H)
3%
6%
12%
7%
12%
3%
Coût des ventes
251,639
244,758
229,276
201,503
187,332
164,871
Bénéfice brut
29,055
30,492
31,018
30,477
28,491
27,039
Vente, Général et Administration
18,688
17,932
19,279
18,914
17,751
16,696
Recherche et développement
2,293
2,162
1,998
1,940
1,827
1,540
Frais d'exploitation
21,584
21,255
22,157
22,162
20,690
19,299
Autres revenus (charges) non opérationnels
-134
-94
-600
-168
-53
26
Bénéfice avant impôts
9,673
8,020
7,054
8,808
8,143
7,175
Charge d'impôt sur le revenu
2,840
2,149
1,887
1,816
1,869
1,570
Bénéfice net
5,645
4,552
3,767
5,617
5,093
4,496
Croissance du bénéfice net
40%
21%
-33%
10%
13%
10%
Actions en circulation (diluées)
3,677.33
3,704.06
3,701.29
3,482.73
2,845.51
2,846
Variation des actions (H-H)
-1%
0%
6%
22%
0%
0%
EPS (dilué)
1.52
1.22
1.01
1.61
1.79
1.58
Croissance du EPS
40%
21%
-37%
-10%
13%
10%
Flux de trésorerie libre
3,216
3,426
2,260
2,058
942
3,834
Flux de trésorerie libre par action
--
--
--
--
--
--
Marge brute
10.35%
11.07%
11.91%
13.13%
13.2%
14.08%
Marge opérationnelle
2.66%
3.35%
3.4%
3.58%
3.61%
4.03%
Marge bénéficiaire
2.01%
1.65%
1.44%
2.42%
2.35%
2.34%
Marge du flux de trésorerie libre
1.14%
1.24%
0.86%
0.88%
0.43%
1.99%
EBITDA
--
10,944
10,417
9,872
9,334
9,311
Marge EBITDA
--
3.97%
4%
4.25%
4.32%
4.85%
D&A pour le résultat opérationnel
--
1,707
1,557
1,557
1,534
1,571
EBIT
7,471
9,237
8,860
8,315
7,800
7,740
Marge EBIT
2.66%
3.35%
3.4%
3.58%
3.61%
4.03%
Taux d'imposition effectif
29.36%
26.79%
26.75%
20.61%
22.95%
21.88%
Statistiques clés
Clôture préc.
$1.46
Prix d'ouverture
$1.46
Plage de la journée
$1.46 - $1.46
Plage de 52 semaines
$1.46 - $15.7
Volume
100
Volume moyen
1
BPA (TTM)
0.21
Rendement en dividend
--
Capitalisation boursière
$5.4B
Qu’est-ce que SHPMF ?
Shanghai Pharmaceuticals Holding Co Ltd is a CN-based company operating in Health Care Providers & Services industry. The company is headquartered in Shanghai, Shanghai and currently employs 49,402 full-time employees. Shanghai Pharmaceuticals Holding Co Ltd is a China-based company principally engaged in pharmaceutical industry, distribution and retail business. The firm's products include innovative drugs, chemical drugs, traditional Chinese medicines and rare disease drugs. The firm's products are mainly used in the cardiovascular system, digestive tract and metabolism, systemic anti-infection, central nervous system, anti-tumor and immunomodulators, musculoskeletal system and respiratory system. In addition, the Company also provides medical logistics and warehousing services. The firm distributes its products both in the domestic market and to overseas markets.